Lastacaft
Loading...Lastacaft Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
LASTACAFT™ is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.
History
There is currently no drug history available for this drug.
Other Information
LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.
Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
Contains: Active: alcaftadine 0.25% (2.5 mg/mL). Preservative: benzalkonium chloride 0.005%. Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid to adjust pH
Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde
Structural Formula:
The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Sources
Lastacaft Manufacturers
-
Physicians Total Care, Inc.
![Lastacaft (Alcaftadine) Solution/ Drops [Physicians Total Care, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Lastacaft | Physicians Total Care, Inc.
Instill one drop in each eye once daily.
-
Rebel Distributors Corp
Lastacaft | Rebel Distributors Corp
Instill one drop in each eye once daily.
-
Allergan, Inc.
Lastacaft | Allergan, Inc.
2.1 Recommended DosingPatient Dosing
One drop of ACUVAIL® should be applied to the affected eye twice daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period.
2.2 Use With Other Topical Ophthalmic MedicationsACUVAIL® ophthalmic solution may be administered in conjunction with other topical ophthalmic medications such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. Drops should be administered at least 5 minutes apart.
![Lastacaft (Alcaftadine) Solution/ Drops [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4b8c6afe-2d76-46c7-a23e-99db5e180ff6&name=4b8c6afe-2d76-46c7-a23e-99db5e180ff6-02.jpg)
![Lastacaft (Alcaftadine) Solution/ Drops [Allergan, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3cea5803-a446-4d2c-9747-f3fb034332c8&name=carton.jpg)
Login To Your Free Account